Have a personal or library account? Click to login

References

  1. 1. Vasanthi P, Nalini G, Rajasekhar G. Status of oxidative stress in rheumatoid arthritis. Int J Rheum Dis 2009; 12(1): 29-33. DOI: 10.1111/j.1756-185X.2009.01375.x.10.1111/j.1756-185X.2009.01375.x
  2. 2. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016; 388(10055): 2023-38. DOI: 10.1016/S0140-6736(16)30173-8.10.1016/S0140-6736(16)30173-8
  3. 3. Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73(7): 1316-22. DOI: 10.1136/annrheumdis-2013-204627.10.1136/annrheumdis-2013-20462724550173
  4. 4. Ungurianu A, Margină D, Grădinaru D, Băcanu C, Ilie M, Tsitsimpikou C, Tsarouhas K, Spandidos DA, Tsatsakis AM. Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease. Mol Med Rep 2017; 15(1): 256-62. DOI: 10.3892/mmr.2016.5972.10.3892/mmr.2016.5972535574327909725
  5. 5. Oliver JE, Silman AJ. Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther 2009; 11(5): 252. DOI: 10.1186/ar2825.10.1186/ar2825278726719863777
  6. 6. Sokka T, Toloza S, Cutolo M et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009; 11(1): R7. DOI: 10.1186/ar2591.10.1186/ar2591268823719144159
  7. 7. Feijóo M, Túnez I, Ruiz A, Tasset I, Muñoz E, Collantes E. Oxidative stress biomarkers as indicator of chronic inflammatory joint diseases stage. Reumatol Clin 2010; 6(2): 91-4. DOI: 10.1016/j.reuma.2008.12.016.10.1016/j.reuma.2008.12.01621794688
  8. 8. Khojah HM, Ahmed S, Abdel-Rahman MS, Hamza AB. Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants. Free Radic Biol Med 2016; 97: 285-91. DOI: 10.1016/j.freeradbiomed.2016.06.020.10.1016/j.freeradbiomed.2016.06.02027344969
  9. 9. Vaya J. Exogenous markers for the characterization of human diseases associated with oxidative stress. Biochimie 2013; 95(3): 578-84. DOI: 10.1016/j.biochi.2012.03.005.10.1016/j.biochi.2012.03.00522429870
  10. 10. Mateen S, Moin S, Zafar A, Khan AQ. Redox signaling in rheumatoid arthritis and the preventive role of polyphenols. Clin Chim Acta 2016; 463: 4-10. DOI: 10.1016/j.cca.2016.10.00710.1016/j.cca.2016.10.00727720800
  11. 11. Bates EJ, Lowther DA, Handley CJ. Oxygen free-radicals mediate an inhibition of proteoglycan synthesis in cultured articular cartilage. Ann Rheum Dis. 1984; 43(3): 462-9. DOI: 10.1136/ard.43.3.46210.1136/ard.43.3.462
  12. 12. Kundu S, Ghosh P, Datta S, Ghosh A, Chattopadhyay S, Chatterjee M. Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic Res 2012; 46(12): 1482-9. DOI: 10.3109/10715762.2012.727991.10.3109/10715762.2012.727991
  13. 13. Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000: 275: 20069–76. DOI: 10.1074/jbc.M90760419910.1074/jbc.M907604199
  14. 14. Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. PLoS One 2016; 11(4): e0152925. DOI: 10.1371/journal.pone.0152925.10.1371/journal.pone.0152925
  15. 15. Kalpakcioglu B, Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, su-peroxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol 2008; 27(2): 141-5. DOI: 10.1007/s10067-007-0746-310.1007/s10067-007-0746-3
  16. 16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–8. DOI: 10.1016/0003-2697(79)90738-3.10.1016/0003-2697(79)90738-3
  17. 17. Green LC, Wagner DA, Glogowski J, Skipper PI, Wish-nok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131–8. DOI: 10.1016/0003-2697(82)90118-x.10.1016/0003-2697(82)90118-X
  18. 18. Auclair C, Voisin E. Nitrobluetetrazolium reduction. In: Greenwald RA (ed) Handbook of methods for oxygen radical research. CRP Press, Boca Raton 1985: pp 123–32.
  19. 19. Pick E, Keisari Y. A simple colometric method for the measurement of hydrogen peroxide by cells in culture. J Immunol Methods 1980;38: 161–70.10.1016/0022-1759(80)90340-3
  20. 20. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 1969;, 244: 6056–63.10.1016/S0021-9258(18)63505-7
  21. 21. Beutler E. Catalase. In: Beutler E (ed) Red cell metabolism, a manual of biochemical methods. Grune and Stratton, New York 1982, pp 105–6.
  22. 22. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxidedismutase. J BiolChem 1972; 247: 3170–5.
  23. 23. Beutler E. Reduced glutathione (GSH). In: Beutler E (ed) Red cell metabolism, a manual of biochemical methods. Grune and Stratton, New York 1975, pp 112–4.
  24. 24. Bauerová K, Bezek A. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys 1999; 18 Spec No: 15-20. DOI: 10.1007/978-3-642-18619-6.10.1007/978-3-642-18619-6
  25. 25. Ristic P, Srejovic I, Nikolic T, Stojic I, Ristic D, Zivkovic V, Jakovljevic VL. The effects of zofenopril on cardiac function and pro-oxidative parameters in the streptozotocin-induced diabetic rat heart. Mol Cell Biochem 2017;, 426(1-2): 183-93. DOI: 10.1007/s11010-016-2890-z10.1007/s11010-016-2890-z27882442
  26. 26. Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 2011; 216(9): 1010-7. DOI: 10.1016/j.imbio.2011.04.001.10.1016/j.imbio.2011.04.00121601309
  27. 27. Desai PB, Manjunath S, Kadi S, Chetana K, Vanishree J. Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study. Eur Rev Med Pharmacol Sci 2010; 14(11): 959-67.
  28. 28. Jaswal S, Mehta HC, Sood AK, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003; 338(1-2): 123-9. DOI. org/10.1016/j.cccn.2003.08.01110.1016/j.cccn.2003.08.01114637276
  29. 29. Sarban S, Kocyigit A, Yazar M, Isikan UE. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005; 38(11): 981-6. DOI: 10.1016/j.clinbiochem.2005.08.003.10.1016/j.clinbiochem.2005.08.00316150434
  30. 30. Pasupathi P, Deepa M, Rani P, Sankar RR. Circulating lipid peroxidation, plasma and erythrocyte antioxidant status in patients with rheumatoid arthritis. Bangladesh Med Res Counc Bull 2009; 35(2): 57-62. DOI:10.3329/bmrcb.v35i2.279810.3329/bmrcb.v35i2.279820120781
  31. 31. Veselinovic M, Barudzic N, Vuletic M, Zivkovic V, Tomic-Lucic A, Djuric D, Jakovljevic V. Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity. Mol Cell Biochem 2014; 391(1-2): 225-32. DOI: 10.1007/s11010-014-2006-6.10.1007/s11010-014-2006-624610042
  32. 32. Al Arfaj AS, Chowdhary AR, Khalil N, Ali R. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Clin. Immunol 2007; 124: 83–9. DOI. org/10.1016/j.clim.2007.03.54810.1016/j.clim.2007.03.54817540620
  33. 33. Cimen MY, Cimen OB, Kacmaz M, Ozturk HS, Yorgancioglu R, Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 2000; 19(4): 275-7. DOI:10.1007/pl0001117210.1007/PL00011172
  34. 34. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1): 44-8. DOI:10.1002/art.178038010710.1002/art.17803801077818570
DOI: https://doi.org/10.2478/sjecr-2018-0047 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 29 - 36
Submitted on: Oct 19, 2018
Accepted on: Oct 26, 2018
Published on: May 29, 2021
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Aleksandra Vranic, Aleksandra Antovic, Nevena Draginic, Marijana Andjic, Marko Ravic, Vladimir Jakovljevic, Mirjana Veselinovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.